Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

445 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumour-necrosis-factor antibody treatment in Crohn's disease.
Derkx B, Taminiau J, Radema S, Stronkhorst A, Wortel C, Tytgat G, van Deventer S. Derkx B, et al. Among authors: van deventer s. Lancet. 1993 Jul 17;342(8864):173-4. doi: 10.1016/0140-6736(93)91375-v. Lancet. 1993. PMID: 8101267 No abstract available.
CD4 antibody treatment in Crohn's disease.
Stronkhorst A, Tytgat GN, van Deventer SJ. Stronkhorst A, et al. Among authors: van deventer sj. Scand J Gastroenterol Suppl. 1992;194:61-5. doi: 10.3109/00365529209096029. Scand J Gastroenterol Suppl. 1992. PMID: 1298050
[Drug treatment of Crohn's disease].
van Deventer SJ, Tytgat GN. van Deventer SJ, et al. Ned Tijdschr Geneeskd. 1998 May 23;142(21):1191-5. Ned Tijdschr Geneeskd. 1998. PMID: 9627451 Review. Dutch.
Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-alpha antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease.
Hommes DW, van Dullemen HM, Levi M, van der Ende A, Woody J, Tytgat GN, van Deventer SJ. Hommes DW, et al. Among authors: van deventer sj, van der ende a, van dullemen hm. Haemostasis. 1997 Nov-Dec;27(6):269-77. doi: 10.1159/000217467. Haemostasis. 1997. PMID: 9731107 Clinical Trial.
Reduction of circulating secretory phospholipase A2 levels by anti-tumor necrosis factor chimeric monoclonal antibody in patients with severe Crohn's disease. Relation between tumor necrosis factor and secretory phospholipase A2 in healthy humans and in active Crohn's disease.
van Dullemen HM, Wolbink GJ, Wever PC, van der Poll T, Hack CE, Tytgat GN, van Deventer SJ. van Dullemen HM, et al. Among authors: van deventer sj, van der poll t. Scand J Gastroenterol. 1998 Oct;33(10):1094-8. doi: 10.1080/003655298750026813. Scand J Gastroenterol. 1998. PMID: 9829366
445 results